Deflazacort for the treatment of Duchenne Dystrophy: A systematic review
2003
Background
To complete a systematic review and meta-analysis based on the clinical question: Is Deflazacort (DFZ), a prednisolone derivative, an effective therapy for improving strength, with acceptable side effects, in children with Duchenne Dystrophy (DD)?
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
53
Citations
NaN
KQI